Staffan Encrantz - 10 Jun 2026 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Jun 2026, 16:43:50 UTC
Prior SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz

Key filing fact

Staffan Encrantz filed Form 4 for Sight Sciences, Inc. (SGHT) on 11 Jun 2026.

Key facts

  • This page summarizes Staffan Encrantz's Form 4 filing for Sight Sciences, Inc. (SGHT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Jun 2026, 16:43.

Change

  • Previous filing in this sequence was filed on 05 Jun 2026.
  • Current net transaction value: +$68,794.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001870875 Primary reporting owner

Encrantz Staffan

Relationship
Director, 10%+ Owner
Address
C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
Signature
/s/Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz
Signature date
11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Purchase

Transaction value
$68,794
Shares
+14,100
Change %
+0.99%
Price
$4.88
Shares after
1,434,283
Date
10 Jun 2026
Ownership
Direct
Footnotes
F1, F2
SGHT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
632,456
Date
10 Jun 2026
Ownership
See footnote
Footnotes
F3
SGHT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,086,920
Date
10 Jun 2026
Ownership
See footnote
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $4.78 to $4.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

Includes (i)1,406,022 shares of Common Stock and (ii) 28,261 restricted stock units, which restricted stock units are subject to vesting as previously reported.

Footnote F3

These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust for purposes of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 under the Exchange Act or for any other purpose), except to the extent of his pecuniary interest therein, if any.

Footnote F4

These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the Chairman and CEO and sole director of Allegro Investment Inc., which is the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund for purposes of Rule 13d-3 under the Exchange Act. However, the Reporting Person does not have any pecuniary interest in the shares held by Allegro Investment Fund and disclaims beneficial ownership with respect to all such shares. Accordingly, these shares are being reported in this report voluntarily by the Reporting Person for informational purposes only and shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares for purposes of Section 16 under the Exchange Act or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .